This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kharfan-Dabaja MA, Ayala E, Greene J, Rojiani A, Murtagh FR, Anasetti C . Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature. Bone Marrow Transplant 2007; 39: 253–254.
Focosi D, Fazzi R, Montanaro D, Emdin M, Petrini M . Progressive multifocal leukoencephalopathy in a haploidentical stem cell transplant recipient: a clinical, neuroradiological and virological response after treatment with risperidone. Antiviral Res 2007; 74: 156–158.
Elphick GF, Querbes W, Jordan JA, Gee GV, Eash S, Manley K et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 2004; 306: 1380–1383.
Altschuler EL, Kast RE . The atypical antipsychotic agents ziprasidone, risperdone and olanzapine as treatment for and prophylaxis against progressive multifocal leukoencephalopathy. Med Hypotheses 2005; 65: 585–586.
Fischman AJ, Bonab AA, Babich JW, Alpert NM, Rauch SL, Elmaleh DR et al. Positron emission tomographic analysis of central 5-hydroxytryptamine 2 receptor occupancy in healthy volunteers treated with the novel antipsychotic agent, ziprasidone. J Pharmacol Exp Ther 1996; 279: 939–947.
Nyberg S, Dahl ML, Halldin C . A PET study of D2 and 5-HT2 receptor occupancy induced by risperidone in poor metabolizers of debrisoquin and risperidone. Psychopharmacology (Berl) 1995; 119: 345–348.
Mannens G, Huang ML, Meuldermans W, Hendrickx J, Woestenborghs R, Heykants J . Absorption, metabolism, and excretion of risperidone in humans. Drug Metab Dispos 1993; 21: 1134–1141.
Rossi A, Delbue S, Mazziotti R, Valli M, Borghi E, Mancuso R et al. Presence, quantitation and characterization of JC virus in the urine of Italian immunocompetent subjects. J Med Virol 2007; 79: 408–412.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kast, R., Focosi, D., Petrini, M. et al. Treatment schedules for 5-HT2A blocking in progressive multifocal leukoencephalopathy using risperidone or ziprasidone. Bone Marrow Transplant 39, 811–812 (2007). https://doi.org/10.1038/sj.bmt.1705682
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705682
This article is cited by
-
Detectable cerebrospinal fluid JCV DNA in late-presenting HIV-positive patients: beyond progressive multifocal leukoencephalopathy?
Journal of NeuroVirology (2017)
-
Update on PML: Lessons from the HIV uninfected and new insights in pathogenesis and treatment
Current HIV/AIDS Reports (2008)
-
Progressive multifocal leukoencephalopathy
Current Treatment Options in Neurology (2008)